org placeholder image

Rebecca Bagley

Executive Director, Clinical Sciences, Revumenib Lead at Syndax Pharmaceuticals

  • LinkedIn

Experienced clinical scientist in oncology from IND submission to post-approval of therapeutics. Proficient in delivering clinical documents and skilled in critically analyzing data. In-d...

Read More

map
SYNDAX PHARMACEUTICALS

SYNDAX PHARMACEUTICALS

  • description Description
    Syndax Pharmaceuticals is a Biotechnology company located at 35 Gatehouse Dr., Building D, Floor 3, Waltham, MA 02451.
  • Employees count Employees 51-200
  • Revenue Revenue 100 Million to 250 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Syndax Pharmaceuticals Org Chart and Mapping

Michael Metzger

Chief Executive Officer, Director

VP-Level

Jeff Crowther

Vice President | VP | Marketing | Sales | Training

Employees

Julie James

Clinical Trial Associate

Rachel Ghiraldi

Director, Regulatory Affairs

Hope Qamoos

Senior Director Clinical Research and Development

Isabella Clemens

Talent Acquisition Coordinator

Myles Clancy

Senior Director, Clinical Scientist

Andrea Larsen

Associate Director, Brand Marketing

Frequently Asked Questions Regarding Rebecca Bagley

Answer: Rebecca Bagley works for Syndax Pharmaceuticals as Executive Director, Clinical Sciences, Revumenib Lead

Answer: Rebecca Bagley’s role in Syndax Pharmaceuticals is Executive Director, Clinical Sciences, Revumenib Lead

Answer: Rebecca Bagley's email address is r***@gmail.com

Answer: Rebecca Bagley's business email address is r****@celldextherapeutics.com

Answer: Rebecca Bagley’s direct phone number is (***)-***-****

Answer: Rebecca Bagley works in the industry of: Biotechnology

Answer: Rebecca Bagley is the current Executive Director, Clinical Sciences, Revumenib Lead at Syndax Pharmaceuticals.... Read More

Answer: Rebecca Bagley works Syndax Pharmaceuticals located at 35 Gatehouse Dr Fl 3 BLDG D, Waltham, Massachusetts, 02451, United States

Answer: Syndax Pharmaceuticals's Executive Director, Clinical Sciences, Revumenib Lead is Rebecca Bagley

Answer: Rebecca Bagley contact details:

  • Phone number  :  (***)-***-****
  • Email  :  r****@celldextherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access